USP <795> Revisions: A Comprehensive Overview

The United States Pharmacopeial Convention (USP) chapter <795>, which sets standards for pharmaceutical compounding of nonsterile preparations, underwent significant revisions that became effective in November 2023. These changes represent the most substantial update to compounding standards in over two decades and have far-reaching implications for pharmacies engaged in compounding activities.

Background and Purpose

The revision process for USP <795> began in response to a changing landscape in pharmaceutical compounding and lessons learned from past compounding-related incidents. The previous version, published in 2009, needed updates to address emerging technologies, enhanced quality assurance practices, and evolving regulatory expectations.

The primary goal of the revised chapter is to provide clear, specific standards that enhance patient safety by ensuring the quality of compounded nonsterile preparations while maintaining flexibility for pharmacies of varying sizes and capabilities.

Key Revisions

Environmental Quality and Design

Perhaps the most significant changes in the revised chapter relate to environmental quality and facility design. The new standards establish more specific requirements for:

• Separate areas for compounding activities to minimize contamination risks
• Dedicated compounding spaces with defined procedures for cleaning and disinfection
• Controlled temperature and humidity in compounding areas
• Enhanced environmental monitoring protocols
• Specified materials for compounding surfaces (smooth, nonporous, cleanable)

Beyond-Use Dating

The revised chapter provides more detailed guidance on establishing beyond-use dates (BUDs) for compounded preparations. Key changes include:

• More conservative default BUDs when stability information is unavailable
• Consideration of specific formulation characteristics in establishing BUDs
• Requirements for maintaining documentation supporting BUD assignments
• Different BUD standards based on water activity in the preparation

Training and Personnel Qualifications

The new chapter emphasizes the importance of personnel training and competency:

• Initial and ongoing training requirements for all compounding personnel
• Documentation of training and competency assessments
• Specific competencies required for different compounding activities
• Training in appropriate personal hygiene and garbing procedures

Quality Assurance and Documentation

The revised chapter strengthens quality assurance requirements:

• Implementation of formal quality assurance programs
• Documentation requirements for all compounding processes
• Procedures for handling complaints or adverse events related to compounded preparations
• Requirements for independent verification of critical compounding steps

Storage and Handling of Components

New standards address the proper storage and handling of compounding components:

• Requirements for maintaining storage conditions within specified parameters
• Standards for inspecting components before use
• Inventory management practices
• Segregation of damaged or expired materials

Implementation Considerations

For pharmacies, implementing the revised USP <795> standards requires careful planning and resource allocation. Key considerations include:

• Facility modifications to meet new environmental and design requirements
• Development of written policies and procedures addressing all relevant standards
• Implementation of training programs and competency assessments
• Establishment of more robust documentation systems
• Allocation of resources for environmental monitoring and quality assurance activities

Impact on Different Pharmacy Settings

The revised chapter acknowledges differences in pharmacy settings and provides some flexibility based on risk assessment:

• Hospital pharmacies may need to modify cleanroom design and implement more formal quality assurance programs
• Community pharmacies may need to establish dedicated compounding areas and enhance documentation practices
• Both settings will need to invest in personnel training and competency assessment programs

Regulatory Compliance

USP chapters are typically incorporated by reference in state pharmacy statutes and regulations. Consequently, most pharmacies will be required to comply with the revised chapter as a matter of law, not just best practice. State boards of pharmacy have begun incorporating the revised standards into their inspection processes.

Conclusion

The revisions to USP <795> represent a significant advancement in compounding standards. While implementation may present challenges for pharmacies, the ultimate benefit is improved patient safety through enhanced quality assurance in the preparation of compounded medications. By embracing these standards, pharmacies demonstrate their commitment to providing the highest quality care to patients who rely on compounded medications.